Join
Live feed
·
PRReleasevia Quantisnow
Checkpoint Therapeutics Inc. logo
Fortress Biotech Inc. logo

Checkpoint Therapeutics Announces Positive Topline Results from the Registration-Enabling Trial of Cosibelimab in Metastatic Cutaneous Squamous Cell Carcinoma

ByQuantisnow·Wall Street's wire, on your screen.
CKPT· Checkpoint Therapeutics Inc.FBIO· Fortress Biotech Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track CKPT (Checkpoint Therapeutics Inc.), FBIO (Fortress Biotech Inc.) and more on Quantisnow.

Checkpoint Therapeutics Announces Positive Topline Results from the Registration-Enabling Trial of Cosibelimab in Metastatic Cutaneous Squamous Cell Carcinoma | Quantisnow